Primary study · included by 1 review
Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.
Adeniyi 2016 · Quirt I C, Shelley W E, Pater J L, et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1991
PubMed 2016615doi:10.1200/jco.1991.9.5.729Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Trial PICO
Not extracted yet. Trial-level population, intervention, comparator, outcomes and design will appear here after the trial extraction run. Until then, the reviews below describe the study.
Results
Not extracted yet. Per-trial results (events, means, effect and weight as each review's forest plot reports them) will appear here after the trial extraction run.
Included by
The review does not say which of its outcomes this study informs.
1 including review in total.